• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes

Posted on: Monday, 1 October 2007, 12:00 CDT

SOMERSET, N.J., Oct. 1 /PRNewswire-FirstCall/ -- inVentiv Health Inc. today announced that it has launched a fourth business segment, inVentiv Patient Outcomes, with a focus on helping pharmaceutical companies and healthcare payors achieve the best possible medical outcomes for patients.

"When patients get on and stay on the right therapy, everyone wins - the healthcare providers, the pharmaceutical companies, the employers, the healthcare payors, and of course, the patients themselves. Unfortunately, patients often don't stay on therapy long enough or don't achieve the optimum results due to reasons ranging from poor training and education, to inability to afford the treatment, to lack of physician involvement," said Blane Walter, President of inVentiv Health. "With our new Patient Outcomes division, inVentiv is uniquely positioned to address these challenges through an array of services that support better patient care."

The inVentiv Patient Outcomes segment includes: * The Therapeutics Institute, which is comprised of approximately 300 nurse educators who can assist physicians and nurses in designing and implementing in-office patient education; * Adheris, which helps educate and motivate patients to stay on therapy by providing pharmacy-based communications programs; * The Franklin Group, which provides access to medication through reimbursement case management services and administers patient assistance programs for those who need financial support to afford their therapy; * AWAC, inVentiv's newest acquisition, which provides disease management support to third-party payors and physicians to ensure better patient outcomes.

The inVentiv Patient Outcomes segment is led by Ed Mitzen, who serves as President of the segment and oversees The Therapeutics Institute, Adheris and The Franklin Group. Mr. Mitzen reports to Terrell Herring, Chief Operating Officer of inVentiv Health. Prior to this role, Mr. Mitzen founded and led two other inVentiv Health companies, CHS and Palio Communications, and served as a Group President in the inVentiv Communications division. Additional leadership for inVentiv Patient Outcomes is provided by Dr. Rick Richards, founder and CEO of AWAC, who also reports to Mr. Herring.

"Across inVentiv Health, most of the services we provide occur before the physician writes the prescription. inVentiv Patient Outcomes is distinct because our focus is on what happens after the prescription is written. We see a significant opportunity to partner with healthcare providers, pharmaceutical companies, pharmacists and payors to help patients get the most from their therapy and ultimately achieve better health," said Mr. Mitzen.

inVentiv Health will be reporting its financials results in four reporting segments beginning with the third quarter 2007.

About inVentiv Health

inVentiv Health, Inc. is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 250 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

inVentiv Health, Inc.

CONTACT: Investors-Corporate: David Bassin, CFO, +1-732-537-4804,investor@inventivhealth.com; or Media: Marcia Frederick, +1-614-543-6281,mfrederick@inventivhealth.com, both of inVentiv Health, Inc.

Web site: http://www.inventivhealth.com/

Source: PRNewswire-FirstCall

More News in this Category